Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,804,303
-$1,455,442 QoQ
Shares Held
324,099
-1.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#477
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 46%
Shared 0%
None 54%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Estabrook Capital Management holds $58,767,979 across 13 Drug Manufacturers - General names. PFE ranks #3 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,720 | $22,786,188 | |
| 2 | MRK |
Merck & Co., Inc.
|
96,811 | $12,440,213 | |
| 3 | PFE |
Pfizer Inc
This page
|
324,099 | $7,804,303 | |
| 4 | AMGN |
Amgen Inc
|
18,721 | $6,779,248 | |
| 5 | LLY |
ELI LILLY & Co
|
3,705 | $4,443,888 | |
| 6 | ABBV |
AbbVie Inc.
|
12,861 | $3,236,342 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,515 | $548,254 | |
| 8 | BIIB |
Biogen Inc.
|
2,000 | $432,120 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,804,303 | 324,099 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,259,745 | 329,763 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,905,641 | 277,335 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,731,906 | 303,450 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $7,730,742 | 318,925 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,635,195 | 301,310 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,853,675 | 296,030 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,432,464 | 360,486 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,101,507 | 361,026 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,986,614 | 359,878 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,070,922 | 315,072 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $11,052,807 | 333,217 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $11,261,090 | 307,009 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $12,550,161 | 307,602 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $15,803,594 | 308,423 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,353,364 | 305,150 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,847,334 | 302,257 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $15,735,336 | 303,947 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $17,936,850 | 303,757 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $13,400,367 | 311,564 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $12,567,344 | 320,923 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $12,085,893 | 333,588 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $12,299,914 | 334,146 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $12,277,348 | 334,533 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,139,757 | 340,665 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $11,282,000 | 345,650 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||